Company
Headquarters: Hangzhou, China
Employees: 400
CEO: Mr. Jianliang Song
HK$198.5 Million
HKD as of Jan. 1, 2024
US$25.4 Million
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services in the People's Republic of China. It operates in two segments, Aesthetic Medical Services and Consulting Services. The company's services include aesthetic surgery services, including aesthetic surgical procedures performed on various parts of the face or body; minimally-invasive aesthetic services, primarily comprising aesthetic injection procedures; aesthetic dermatology services, such as various aesthetic energy-based procedures; and aesthetic medical management consulting services, as well as offers aesthetic training courses. It also offers aesthetic dental services, including orthodontics, and dental implant and whitening; and trades in medical equipment. As of December 31, 2020, the company owned and operated a network of four private for-profit aesthetic medical institutions in Zhejiang and Anhui Province, the People's Republic of China. It serves individual retail clients and physicians, and aesthetic medical institutions. The company was founded in 2008 and is headquartered in Hangzhou, the People's Republic of China.
Top 1-year algo backtest: +287.69%
$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Raily Aesthetic Medicine International Holdings Ltd has the following listings and related stock indices.
Stock: HKEX: 2135 wb_incandescent